Learn More
Overview
Hyperfine developed the world's first FDA-cleared portable MRI system — the Swoop — which brings MRI scanning to bedside rather than requiring patients to be transported to a fixed MRI suite. The Swoop operates at a fraction of the magnetic field strength of conventional MRI (0.064T vs 1.5–3T), making it safe in standard hospital rooms without MRI-shielded suites. AI is central to the technology: deep learning algorithms enhance image quality, compensate for the lower field strength, and help detect neurological conditions from the resulting images.
Hyperfine's AI image enhancement is particularly sophisticated — transforming images from a low-field portable scanner into diagnostically useful neurological imaging. Algorithms trained on hundreds of thousands of brain images remove artifacts, improve resolution, and highlight clinically relevant findings. This AI capability is what makes the Swoop clinically viable despite its portable, low-field design.
In 2026, Hyperfine's Swoop is deployed in ICUs, emergency departments, and pediatric wards at hospitals globally. The ability to bring MRI to critically ill patients who can't safely be transported — ventilated ICU patients, hemodynamically unstable patients, neonates — represents a clinical capability that didn't previously exist.
Key Features
Portable Bedside MRI
Roll-to-bedside MRI for patients who cannot be safely transported. Operates in standard hospital rooms without specialized infrastructure.
AI Image Enhancement
Deep learning algorithms enhance image quality from low-field scanning to diagnostic utility. Compensates for reduced field strength with AI signal processing.
AI Pathology Detection
AI assists with identifying neurological findings: hemorrhage, ischemia, hydrocephalus, and other conditions from Swoop images.
FDA Cleared & CE Marked
Full regulatory clearance for clinical neurological imaging. Cleared for brain imaging across multiple indications.
ICU & Critical Care Focus
Specifically designed for use in ICU, NICU, and emergency settings where patient transport for conventional MRI is high-risk or impossible.
Remote Interpretation Support
Telemedicine integration allows neurologists to review Swoop images remotely. Expands specialist access for facilities without on-site neurology.
Pros & Cons
Advantages
- Unique capability (portable MRI doesn't exist otherwise)
- Enables imaging previously impossible for critically ill patients
- FDA cleared for clinical use
- AI enhancement makes low-field clinically useful
- Expands MRI access in resource-limited settings
Disadvantages
- Image quality lower than conventional MRI (despite AI enhancement)
- Limited to neurological brain imaging (not full-body MRI)
- High device cost
- Specialized clinical use case
Pricing Plans
| Plan | Price | Model | Key Features |
|---|---|---|---|
| Device Purchase | Contact Sales | Capital purchase | Full ownership, one-time cost |
| Per-Scan | Contact Sales | Usage-based | Pay-per-scan payment model |
| Software/AI | Included | Subscription | Included with device, subscription for updates |
Best Use Cases
Hyperfine Excels At:
- ICU neurological monitoring for critically ill patients
- Emergency brain imaging without transport risk
- NICU neonatal neurological imaging
- Resource-limited hospitals needing affordable neuroimaging
- Serial monitoring avoiding repeated patient transport
May Not Be Ideal For:
- Replacing conventional MRI for stable outpatients
- Body MRI (brain-focused only)
- Settings with accessible conventional MRI suites
- Small clinics without ICU/acute care focus
How It Compares
Hyperfine vs Conventional MRI
Conventional MRI delivers higher image quality. Swoop enables imaging when conventional MRI is impossible due to patient instability or lack of access. They serve different but complementary clinical needs.
Hyperfine vs Qure.ai
Qure.ai focuses on AI analysis of chest X-rays and CT scans. Hyperfine focuses on portable MRI hardware with AI enhancement. Different modalities and clinical applications.
Final Verdict
Our Recommendation
Hyperfine has done something remarkable — made MRI available to patients for whom it was previously impossible. The combination of portable hardware and AI image enhancement creates a genuinely new clinical capability: bedside neurological MRI for critically ill patients. The FDA clearance and growing hospital adoption demonstrate clinical acceptance. For neurocritical care units and hospitals in resource-limited settings, Hyperfine's Swoop addresses an unmet need that has real patient outcome implications.